Topical Antifungal Treatment for Tinea Cruris

To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris

Lead sponsor: Medicis Global Service Corporation•17 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDPhase 4

Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris

NCT02394340 · Tinea Pedis, Tinea Cruris

UNKNOWNPhase 3

Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections

NCT01105013 · Fungal Infections, Tinea Pedis, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 28, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment483

Start dateMay 2011

Last updatedAug 28, 2013

Condition

Tinea Cruris

Locations shown

Fremont, California

Los Angeles, California

Miami, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2013Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions